Dihexa: Dihexa is derived from angiotensin IV and acts by binding hepatocyte growth factor (HGF) with high affinity, potentiating HGF/c-Met receptor signaling at subthreshold concentrations
Stickel, F., Datz, C., Hampe, J
The method of embodiment 134, wherein the composition comprises between about 0.01% to about 20% by weight of the poloxamer, about 0.01% to about 15% by weight of the poloxamer, about 0.01% to about 10% by weight of the poloxamer, about 0.01% to about 7% by weight of the poloxamer, about 0.01% to about 5% by weight of the poloxamer, about 0.01% to about 3% by weight of the poloxamer, about 0.01% to about 2% by weight of the poloxamer, or about 0.01% to about 1% by weight of the poloxamer
Within the last decade, the brain was identified as a target organ for APAP toxicity in newborn laboratory mice based on profound, long-term loss of cognitive function observed following exposure to relatively low drug doses [12]
Galantamine-loaded solidlipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations